Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Herrmann

Showing results (11-20 of 403) with videos related to

Pageof 41
Sort By:
Innovative Surgical Sciences|December 25, 2025
Influence of the COVID-19 pandemic on the amputation rate in Germany in patients with critical limb-threatening ischaemiaWojciech Derwich, Oliver Schöffski, Eva Herrmann, et al.
Journal of Virology|October 9, 2002
Hepatitis C virus nonstructural 5A protein and interferon resistance: a new model for testing the reliability of mutational analysesChristoph Sarrazin, Eva Herrmann, Katharina Bruch, et al.
Plos One|March 14, 2013
Aprotinin may increase mortality in low and intermediate risk but not in high risk cardiac surgical patients compared to tranexamic acid and ε-aminocaproic acid -- a meta-analysis of randomised and observational trials of over 30.000 patientsPatrick Meybohm, Eva Herrmann, Julia Nierhoff, et al.
Inflammatory Bowel Diseases|November 20, 2009
Methotrexate for maintenance of remission in chronic active Crohn's disease: long-term single-center experience and meta-analysis of observational studiesJohannes Hausmann, Kai Zabel, Eva Herrmann, et al.
Reviews in Endocrine & Metabolic Disorders|September 18, 2016
Relapse prediction in Graves´ disease: Towards mathematical modeling of clinical, immune and genetic markersChristoph Langenstein, Diana Schork, Klaus Badenhoop, et al.
Klinische Monatsblatter Fur Augenheilkunde|August 16, 2017
[Comparison of Discriminant Analysis and Decision Trees for the Detection of Subclinical Keratoconus]Sonja Kleinhans, Eva Herrmann, Thomas Kohnen, et al.
Annals of Surgery Open : Perspectives of Surgical History, Education, and Clinical Approaches|December 26, 2025
External Validation of the COMI-Hernia Score and Establishing Minimal Important Difference for Assessing Postoperative Quality of Life Following Inguinal Hernia RepairFraidoon Nazemi, Eva Herrmann, Ernst Hanisch, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 6, 2008
Ribavirin mode of action in chronic hepatitis C: from clinical use back to molecular mechanismsWolf Peter Hofmann, Eva Herrmann, Christoph Sarrazin, et al.
International Journal of Molecular Sciences|March 29, 2023
The APSANTICO Study: A Prospective Observational Study to Evaluate Antiphospholipid Antibody Profiles in Patients with Thromboembolic Antiphospholipid Syndrome (APS) after COVID-19 Infection and/or VaccinationOlivia Ott, Eva Herrmann, Annabel Schulz, et al.
Journal of Clinical Medicine|August 26, 2022
Thromboembolic Antiphospholipid Syndrome (APS): Efficacy and Safety of Different Anticoagulants-Results of the APSantiCO RegistryAnnabel Schulz, Eva Herrmann, Olivia Ott, et al.
Pageof 41

Showing results (11-20 of 403) with videos related to

Sort By:
Pageof 41
Innovative Surgical Sciences|December 25, 2025
Influence of the COVID-19 pandemic on the amputation rate in Germany in patients with critical limb-threatening ischaemiaWojciech Derwich, Oliver Schöffski, Eva Herrmann, et al.
Journal of Virology|October 9, 2002
Hepatitis C virus nonstructural 5A protein and interferon resistance: a new model for testing the reliability of mutational analysesChristoph Sarrazin, Eva Herrmann, Katharina Bruch, et al.
Plos One|March 14, 2013
Aprotinin may increase mortality in low and intermediate risk but not in high risk cardiac surgical patients compared to tranexamic acid and ε-aminocaproic acid -- a meta-analysis of randomised and observational trials of over 30.000 patientsPatrick Meybohm, Eva Herrmann, Julia Nierhoff, et al.
Inflammatory Bowel Diseases|November 20, 2009
Methotrexate for maintenance of remission in chronic active Crohn's disease: long-term single-center experience and meta-analysis of observational studiesJohannes Hausmann, Kai Zabel, Eva Herrmann, et al.
Reviews in Endocrine & Metabolic Disorders|September 18, 2016
Relapse prediction in Graves´ disease: Towards mathematical modeling of clinical, immune and genetic markersChristoph Langenstein, Diana Schork, Klaus Badenhoop, et al.
Klinische Monatsblatter Fur Augenheilkunde|August 16, 2017
[Comparison of Discriminant Analysis and Decision Trees for the Detection of Subclinical Keratoconus]Sonja Kleinhans, Eva Herrmann, Thomas Kohnen, et al.
Annals of Surgery Open : Perspectives of Surgical History, Education, and Clinical Approaches|December 26, 2025
External Validation of the COMI-Hernia Score and Establishing Minimal Important Difference for Assessing Postoperative Quality of Life Following Inguinal Hernia RepairFraidoon Nazemi, Eva Herrmann, Ernst Hanisch, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 6, 2008
Ribavirin mode of action in chronic hepatitis C: from clinical use back to molecular mechanismsWolf Peter Hofmann, Eva Herrmann, Christoph Sarrazin, et al.
International Journal of Molecular Sciences|March 29, 2023
The APSANTICO Study: A Prospective Observational Study to Evaluate Antiphospholipid Antibody Profiles in Patients with Thromboembolic Antiphospholipid Syndrome (APS) after COVID-19 Infection and/or VaccinationOlivia Ott, Eva Herrmann, Annabel Schulz, et al.
Journal of Clinical Medicine|August 26, 2022
Thromboembolic Antiphospholipid Syndrome (APS): Efficacy and Safety of Different Anticoagulants-Results of the APSantiCO RegistryAnnabel Schulz, Eva Herrmann, Olivia Ott, et al.
Pageof 41